Rigorous epidemiologic studies on the incidence and prevalence of overlap syndromes have not been done, and data are lacking. However, they are all rare conditions. One population-based study following a US cohort between 1985-2014 found the annual incidence of mixed connective tissue disease (MCTD) was 1.9 per 100,000.[5]Ungprasert P, Crowson CS, Chowdhary VR, et al. Epidemiology of mixed connective tissue disease, 1985-2014: a population-based study. Arthritis Care Res (Hoboken). 2016 Dec;68(12):1843-8.
https://acrjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/acr.22872
http://www.ncbi.nlm.nih.gov/pubmed/26946215?tool=bestpractice.com
At a tertiary US referral center, it was found to be less common than systemic lupus erythematosus (SLE), as common as systemic sclerosis, and more common than polymyositis.[6]Hoffman Robert W. 152 - Overlap syndromes. In: Hochberg Marc C, Silman Alan J, Smolen Josef S. et al., eds. Rheumatology. 6th ed. Maryland Heights, MO: Mosby; 2015, 1264-9. Like SLE, MCTD is far more common in women (female to male ratio ranging from 3.3:1 to 5:1).[5]Ungprasert P, Crowson CS, Chowdhary VR, et al. Epidemiology of mixed connective tissue disease, 1985-2014: a population-based study. Arthritis Care Res (Hoboken). 2016 Dec;68(12):1843-8.
https://acrjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/acr.22872
http://www.ncbi.nlm.nih.gov/pubmed/26946215?tool=bestpractice.com
[7]Gunnarsson R, Molberg O, Gilboe IM, et al. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011 Jun;70(6):1047-51.
http://www.ncbi.nlm.nih.gov/pubmed/21398332?tool=bestpractice.com
[8]Ferrara CA, La Rocca G, Ielo G, et al. Towards early diagnosis of mixed connective tissue disease: updated perspectives. Immunotargets Ther. 2023 Jul 26:12:79-89.
https://www.dovepress.com/towards-early-diagnosis-of-mixed-connective-tissue-disease-updated-per-peer-reviewed-fulltext-article-ITT
http://www.ncbi.nlm.nih.gov/pubmed/37525698?tool=bestpractice.com
No familial clustering has been noted.
Antisynthetase antibodies (including anti-Jo-1, an antibody directed against histidyl-tRNA synthetase) are found in 5% to 20% of patients with polymyositis or dermatomyositis.[9]White A, Flaris N, Elmer D, et al. Coexistence of mucinous cystadenoma of the ovary and ovarian sarcoidosis. Am J Obstet Gynecol. 1990 May;162(5):1284-5.
http://www.ncbi.nlm.nih.gov/pubmed/2339730?tool=bestpractice.com